Open Access

Primary and Secondary Bacteremia Caused by Proteus spp.: Epidemiology, Strains Susceptibility and Biofilm Formation


Cite

Fig. 1.

The Dienes phenomenon: A) non-identical strains, B) identical strains.
The Dienes phenomenon: A) non-identical strains, B) identical strains.

Fig. 2.

Antibiotic susceptibility of ESBLs(+) and ESBLs(–) Proteus spp. strains (n = 98) isolated from bacteremia; p-value of chi2 testing between susceptible and non-susceptible (resistant and intermediate) strains; abbreviations of antibiotic names (see Table III).
Antibiotic susceptibility of ESBLs(+) and ESBLs(–) Proteus spp. strains (n = 98) isolated from bacteremia; p-value of chi2 testing between susceptible and non-susceptible (resistant and intermediate) strains; abbreviations of antibiotic names (see Table III).

Genetic similarity of P. mirabilis isolates (n = 26).

Demographic and clinical parameters of patients with Proteus spp. BSIs (n = 83).

VariableDeath in 14 days (n = 24)Survival (n = 59)p-value*
Age (years), median (min-max)77.5 (55–94)67.0 (12–88)0.0025**
SexMen, No. (%)13 (54.2)33 (55.9)0.9229
Women, No. (%)11 (45.8)26 (44.1)
Length of stay in hospital (days), median (min-max)19.5 (1–139)38 (5–406)0.0142**
Length of stay in hospital before Proteus spp. BSI (days), median (min-max)9.5 (0–138)7.5 (0–380)1.0000**
Primary bacteremia, No. (%)11 (45.8)23 (39.0)0.7420
Secondary bacteremia, No. (%)13 (54.2)36 (61.0)
Adequate empiric antibiotic therapy, No. (%)16 (66.7)43 (72.9)0.7648
More than one strain in blood culture, No. (%)9 (37.5)20 (34.0)0.9537
ESBL Proteus spp., No. (%)4 (16.7)11 (18.6)0.9185
Predisposing factorsUrinal catheter, No. (%)18 (75.0)44 (67.8)0.8117
Central Venus Catheter, No. (%)15 (62.5)28 (47.5)0.3168
Diabetes, No. (%)7 (29.2)10 (16.9)0.3419
Hospitalization during past half year, No. (%)13 (54.2)25 (42.4)0.4625
Cancer, No. (%)3 (12.5)4 (6.8)0.6784
Surgery during past half year, No. (%)9 (37.5)33 (55.9)0.2003
Cardio-vascular diseases, No. (%)15 (62.5)23 (39.0)0.0879
Chronic wounds, No. (%)7 (29.2)13 (22.0)0.6849

The strains isolated from patients with P. mirabilis (n = 93) and P. vulgaris (n = 5) bacteremia.

Yearspp. bacteremia ProtteusSecondary Proteus spp. bacteremiaIsolation of Proteus spp. not related directly to bacteremia
TotalSource of secondary bacteremia (strains isolated at the time/up to three days before isolation from blood sample)Before bacteremia (more than three days)After bacteremia
Urinary tractRespiratory tractWoundsBlood catheterPeritoneumRespiratory tractWoundsUrinary tractBlood catheterPeritoneumRespiratory tractWoundsUrinary tractBlood catheterPeritoneum
2009128 (66.7%)710001020001100
2010128 (66.7%)402200200004120
201174 (57.1%)102010201100100
201244 (100.0%)111100010000010
2013148 (57.1%)222203210002011
2014149 (64.3%)503100210010001
201594 (44.4%)112000000011100
2016158 (53.3%)511100110011000
2017115 (45.5%)121010010022110
Total9858 (59.2%)278147249711511552

Antibacterial agents (Aas) susceptibility of Proteus spp. strains (n = 98) isolated from bacteremia.

AasPrimary bacteremia Aas susceptibilityp*Secondary bacteremia Aas susceptibilityTotal Aas susceptibility
SIRSIRSIR
n%n%n%n%n%n%n%n%n%
AMC922.52460.0717.50.45881627.62848.31424.12525.55253.12121.4
TZP40100.000.000.00.13165493.100.046.99495.900.044.1
CMX2870.000.01230.00.60374577.600.01322.47374.500.02525.5
CTX3177.500.0922.50.33934679.300.01220.77778.600.02121.4
CAZ3587.525.037.50.16975187.900.0712.18687.822.01010.2
FEP3280.025.0615.00.42544882.846.9610.38081.666.11212.2
IMP3075.0820.025.00.60624984.5813.811.77980.61616.333.1
GEN2972.512.51025.00.36624679.311.71119.07576.522.02121.4
AMK3382.537.5410.00.63115289.746.923.48586.777.166.1
CIP2460.012.51537.50.43363865.558.61525.96263.366.13030.6
SXT2050.000.02050.00.31652848.300.03051.74849.000.05051.0
eISSN:
2544-4646
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Life Sciences, Microbiology and Virology